Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T20:35:29.410Z.
Calculation as of: 2026-10-06T20:35:29.410Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
EARNINGS YIELD
N/A
Market Cap
$753.02M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$761.37M
Earnings Yield
0.62%
TTM Avg
0.83%
3Y Avg
0.56%
5Y Avg
0.44%
Market Cap
$721.69M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$714.37M
Earnings Yield
N/A
TTM Avg
0.35%
3Y Avg
0.35%
5Y Avg
0.35%
Market Cap
$709.65M
Earnings Yield
5.67%
TTM Avg
4.56%
3Y Avg
4.80%
5Y Avg
6.03%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apnimed, Inc. (APMD) | $742.70M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $747.61M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.02M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $761.37M | 0.62% | 0.83% | 0.56% | 0.44% |
| Candel Therapeutics, Inc. (CADL)vs › | $723.18M | N/A | N/A | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $721.69M | N/A | N/A | N/A | N/A |
| Sana Biotechnology, Inc. (SANA)vs › | $765.30M | N/A | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $714.37M | N/A | 0.35% | 0.35% | 0.35% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.65M | 5.67% | 4.56% | 4.80% | 6.03% |
| Geron Corporation (GERN)vs › | $776.24M | N/A | 0.17% | 0.17% | 0.17% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
